Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| + | *[[Media:2019_10-08_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | October 8, 2019]] | ||
*[[Media:2019_09-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | September 10, 2019]] | *[[Media:2019_09-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | September 10, 2019]] | ||
*[[Media:2019_08-13_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 13, 2019]] | *[[Media:2019_08-13_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 13, 2019]] | ||
Revision as of 16:22, 18 October 2019
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- RSNA Staff Support: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
- October 8, 2019
- September 10, 2019
- August 13, 2019
- July 9, 2019
- May 14, 2019
- April 9, 2019
- March 12, 2019
SPECT TC99m BC Call Summaries Archive